
We have identified five derivatives of the natural product zzso A that are potent against multiple drug-resistant colon cancer cell zzso These zzso share no structural zzso to current colon cancer drugs, are zzso at levels on par with existing drugs treating other zzso and demonstrate selectivity for drug-resistant colon cancer cell lines over zzso cell zzso Thus, we have established zzso A as a privileged structure for treating multiple drug-resistant colon zzso 

